New service launches, and agreements & collaborations were key growth strategies adopted by leading market players in the global next generation sequencing services market
The global next-generation sequencing services market is expected to grow at a CAGR of 21.0% between 2017 and 2022. Factors driving the growth of this market include the technological advancements in the field of sequencing and the declining price of sequencing, among others.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=194102241
As of 2016, BGI (China), Eurofins Scientific SE (Luxembourg), Macrogen Inc. (South Korea), PerkinElmer, Inc. (U.S.), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), GATC Biotech AG (Germany), QIAGEN (Germany), DNA Link, Inc (South Korea), Genotypic Technology Pvt Ltd (India), LGC Limited (U.K.), Wuxi Apptech Co. Ltd. (China), Zymo Research Corp (U.S.), Source BioScience (U.K.), and Personalis, Inc. (U.S.) are some of the major NGS services providers for this market
Analysis of the market developments between 2014 and 2017 (June) show that product launches, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market position by collaborating to improve sequencing capabilities and enhance their sales.
In 2016, BGI (China) held the leading position in the global NGS Services market, through its broad portfolio of advanced NGS services. The end users for the company include medical institutions and research institutions. The company possesses expertise in prenatal screening, hereditary cancer screening, and rare genetic disease testing and precision medicine research. The company has a strong network of healthcare companies, scientific partners, and pharmaceutical companies. The company is very dynamic and adopts the strategy of partnerships and collaborations to strengthen its position in the NGS services market.
Eurofins Scientific SE (Luxembourg) is one of the leading players in the NGS services market, in 2016. The company offers a wide range of NGS services including sequence capture, transcriptome analysis, library generation service, ultra-deep sequencing, bioinformatics services, and de novo sequencing. To strengthen its current position, the company focused on inorganic growth strategies like mergers and acquisitions to expand its NGS services portfolio. For instance, Eurofins Scientific acquired Emory Genetics Laboratory (Europe) to expand its network of NGS services.
Know More:
https://www.marketsandmarkets.com/Market-Reports/ngs-services-market-194102241.html
The global next-generation sequencing services market is expected to grow at a CAGR of 21.0% between 2017 and 2022. Factors driving the growth of this market include the technological advancements in the field of sequencing and the declining price of sequencing, among others.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=194102241
Analysis of the market developments between 2014 and 2017 (June) show that product launches, agreements, and collaborations were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market position by collaborating to improve sequencing capabilities and enhance their sales.
In 2016, BGI (China) held the leading position in the global NGS Services market, through its broad portfolio of advanced NGS services. The end users for the company include medical institutions and research institutions. The company possesses expertise in prenatal screening, hereditary cancer screening, and rare genetic disease testing and precision medicine research. The company has a strong network of healthcare companies, scientific partners, and pharmaceutical companies. The company is very dynamic and adopts the strategy of partnerships and collaborations to strengthen its position in the NGS services market.
Eurofins Scientific SE (Luxembourg) is one of the leading players in the NGS services market, in 2016. The company offers a wide range of NGS services including sequence capture, transcriptome analysis, library generation service, ultra-deep sequencing, bioinformatics services, and de novo sequencing. To strengthen its current position, the company focused on inorganic growth strategies like mergers and acquisitions to expand its NGS services portfolio. For instance, Eurofins Scientific acquired Emory Genetics Laboratory (Europe) to expand its network of NGS services.
Know More:
https://www.marketsandmarkets.com/Market-Reports/ngs-services-market-194102241.html
No comments:
Post a Comment